Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.
Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.
复制标题
组织转谷氨酰胺酶组成性地通过非经典途径激活HIF-1α启动子和核因子-κB。
DOI:
10.1371/journal.pone.0049321
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Mehta K
中科院分区:
文献类型:
--
作者:
Kumar S;Mehta K
Constitutive activation of nuclear factor kappa B (NF-κB) has been linked with carcinogenesis and cancer progression, including metastasis, chemoresistance, and radiation resistance. However, the molecular mechanisms that result in constitutive activation of NF-κB are poorly understood. Here we show that chronic expression of the pro-inflammatory protein tissue transglutaminase (TG2) reprograms the transcription regulatory network in epithelial cells via constitutive activation of NF-κB. TG2-induced NF-κB binds the functional NF-κB binding site in hypoxia-inducible factor-1 (HIF-1α) promoter and results in its increased expression at transcription and protein levels even under normoxic conditions. TG2/NF-κB-induced HIF-1 was deemed essential for increased expression of some transcription repressors, like Zeb1, Zeb2, Snail, and Twist. Unlike tumor necrosis factor-alpha (TNFα), TG2 did not require IκB kinase (IKK) for NF-κB activation. Our data suggest that TG2 binds with IκBα and results in its rapid degradation via a non-proteasomal pathway. Importantly, the catalytically inactive (C277S) mutant form of TG2 was as effective as was wild-type TG2 in activating NF-κB and inducing HIF-1 expression. We also found that TG2 interacted with p65/RelA protein, both in the cytosolic and the nuclear compartment. The TG2/p65(NF-κB) complex binds to the HIF-1 promoter and induced its transcriptional regulation. Inhibition of TG2 or p65/RelA also inhibited the HIF-1α expression and attenuated Zeb1, Zeb2, and Twist expression. To our knowledge, these findings show for the first time a direct link between TG2, NF-κB, and HIF-1α, demonstrating TG2's important role in cancer progression.
登录
查看更多内容
影响因子:
29
作者:
Baker RG;Hayden MS;Ghosh S
通讯作者:
Ghosh S
影响因子:
11.2
作者:
Hwang JY;Mangala LS;Fok JY;Lin YG;Merritt WM;Spannuth WA;Nick AM;Fiterman DJ;Vivas-Mejia PE;Deavers MT;Coleman RL;Lopez-Berestein G;Mehta K;Sood AK
通讯作者:
Sood AK
DOI:
10.1186/bcr3085
发表时间:
2012-01-06
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Kumar A;Xu J;Sung B;Kumar S;Yu D;Aggarwal BB;Mehta K
通讯作者:
Mehta K
影响因子:
4.8
作者:
Lee, JM;Kim, YS;Kim, SY
通讯作者:
Kim, SY
影响因子:
4.7
作者:
Cao, Liyun;Petrusca, Daniela N.;Matei, Daniela
通讯作者:
Matei, Daniela